Simple Summary Oral cancer may strongly impair patients' quality of life. Huge efforts have
been made during recent decades in trying to improve the treatment outcomes in terms of …

A combination of monoclonal antibodies prescribed along with the conventional standard of
care has a potential to provide significant improvement in patients suffering from head and …

Opinion statement The demographics of head and neck cancer (HNC) survivors are
changing, contributing to a growing number of survivors and a greater length of survivorship …

Background: Intensity-modulated radiotherapy (IMRT) with simultaneous integrated boost
(SIB) and moderate hypofractionation offers an opportunity for defining individual doses and …

Background To analyze the prognostic factors associated with stage IB-IVA cervical cancer
in patients who underwent concurrent chemoradiation therapy (CCRT) and to compare the …

Objective Episil® is a bio adhesive barrier-forming oral liquid gel that has been used in
recent years to relieve pain of oral mucositis (OM) with radiotherapy (RT) or …

Abstract Background Sequential treatment of Panitumumab (Pb) plus Paclitaxel (Px) as
induction treatment (IT) followed by concurrent bioradiotherapy (Bio–RT) with Pb may be an …

Background Tri-weekly cisplatin and radiotherapy (CDDP+ RT) is a standard of care for
locally advanced head and neck squamous cell carcinoma (LA-HNSCC) but is sometimes …

Dear Editor, We would like to congratulate Thaduri et al. on their study that used a patient-
reported outcome questionnaire to assess the long-term swallowing results and quality of …

Background: This study was performed to evaluate the impact of upgrade of radiotherapy
system, including launch of intensity-modulated radiation therapy (IMRT), on the therapeutic …